First patient enrolled in AZURE-2 study comparing brelovitug to Hepcludex
Category: News
Novel orexin receptor agonist shows potential to improve wakefulness
Topical TRPV1 antagonist shows promise in heat-induced neuropathic pain
Trial explores regenerative macrophage therapy for liver disease
Deal covers biosimilars for gastroenterology, neurology and dermatology
Collaboration offers end-to-end support from donor sourcing to manufacturing
New subcutaneous autoinjector offers at-home treatment option for patients
MHRA grants conditional authorisation for treatment targeting mantle cell lymphoma
Swedish biotech company Akiram Therapeutics has announced significant progress in its first clinical trial of AKIR001, a radiopharmaceutical […]
The US Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application from Coya Therapeutics […]